Valuation: WntResearch AB

Market Cap 123M 12.91M 11.23M 10.45M 9.59M 18.12M 1.23B 18.4M 48.34M 614M 48.5M 47.43M 2.06B P/E 2024 *
-
P/E 2025 -4.79x
Enterprise Value 123M 12.93M 11.24M 10.46M 9.61M 18.14M 1.23B 18.42M 48.41M 615M 48.57M 47.5M 2.06B EV / Sales 2024 *
-
EV / Sales 2025 8,542,354x
Free-Float
1.03%
Yield 2024 *
-
Yield 2025 -
Change 5-day change 1-year change 3-year change Capi.($)
+3.35%-13.20% - - 12.91M
+2.35%+2.74%+33.41%+79.20% 56.54B
-0.21%-7.38%+25.34%+63.02% 53.6B
-2.44%+1.40%-15.74%-16.80% 22.91B
-2.85%-7.78%-8.09%+346.36% 21.37B
+2.49%-0.92%+20.31%-12.15% 20.27B
+0.79%-1.06%+29.29%-33.32% 17.56B
+0.58%-5.88%+16.30%+540.37% 14.75B
-5.25%-4.23%+46.41%+169.05% 13.33B
+3.41%-6.61%+163.08%+280.43% 13.53B
Average +0.22%-3.79%+34.48%+157.35% 25.98B
Weighted average by Cap. +0.23%-2.96%+28.67%+119.98%

Financials

2024 2025
Net sales - 9.68 1.02 0.88 0.82 0.75 1.42 96.92 1.45 3.8 48.25 3.81 3.73 161.79
Net income -46.5M -4.88M -4.24M -3.94M -3.62M -6.84M -465M -6.95M -18.25M -232M -18.31M -17.91M -777M -17.23M -1.81M -1.57M -1.46M -1.34M -2.53M -172M -2.57M -6.76M -85.86M -6.79M -6.64M -288M
Net Debt -5.26M -551K -479K -446K -410K -773K -52.63M -785K -2.06M -26.2M -2.07M -2.02M -87.85M 185K 19.4K 16.86K 15.69K 14.41K 27.21K 1.85M 27.63K 72.61K 922K 72.85K 71.25K 3.09M
Logo WntResearch AB
Opsy Holding AB, formerly WntResearch AB, is a Sweden-based company engaged in the translational cancer research. Its aim is to develop anti-metastatic therapies based on an increased understanding of the mechanisms underlying the metastatic process and the evaluation of specific small molecules that can specifically interact with this process. The Company’s programs focus on the role of the Wnt-5a protein in the metastatic process.
Employees
7